{"protocolSection": {"identificationModule": {"nctId": "NCT02041221", "orgStudyIdInfo": {"id": "SPARC_Ltd_ CLR_13_16"}, "organization": {"fullName": "Sun Pharma Advanced Research Company Limited", "class": "INDUSTRY"}, "briefTitle": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316"}, "statusModule": {"statusVerifiedDate": "2016-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-01"}, "primaryCompletionDateStruct": {"date": "2014-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-01-14", "studyFirstSubmitQcDate": "2014-01-17", "studyFirstPostDateStruct": {"date": "2014-01-20", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-12-14", "resultsFirstSubmitQcDate": "2016-03-01", "resultsFirstPostDateStruct": {"date": "2016-03-31", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2016-04-21", "lastUpdatePostDateStruct": {"date": "2016-05-23", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Sun Pharma Advanced Research Company Limited", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Sun Pharma Advanced Research company Limited has developed a dry powder inhaler of compound SPARC1316 for oral inhalation. This clinical study is a Phase I/IIa study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of S0597 administered by oral inhalation to healthy volunteers and asthma patients."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["pharmacokinetics, pharmacodynamics, asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE1", "PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 64, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "SPARC1316 Dose 1", "type": "EXPERIMENTAL", "description": "Subjects will be administered with SPARC1316 dose 1", "interventionNames": ["Drug: SPARC1316 Dose 1"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "The subjects will receive placebo.", "interventionNames": ["Drug: Placebo"]}, {"label": "SPARC1316 Dose 2", "type": "EXPERIMENTAL", "description": "Subjects will be administered with SPARC1316 dose 2", "interventionNames": ["Drug: SPARC1316 Dose 2"]}, {"label": "SPARC1316 Dose 3", "type": "EXPERIMENTAL", "description": "Subjects will be administered with SPARC1316 dose 3", "interventionNames": ["Drug: SPARC1316 Dose 3"]}, {"label": "SPARC1316 Dose 4", "type": "EXPERIMENTAL", "description": "Subjects will be administered with SPARC1316 dose 4", "interventionNames": ["Drug: SPARC1316 Dose 4"]}, {"label": "SPARC1316 Dose 5", "type": "EXPERIMENTAL", "description": "Subjects will be administered with SPARC1316 dose 5", "interventionNames": ["Drug: SPARC1316 Dose 5"]}], "interventions": [{"type": "DRUG", "name": "SPARC1316 Dose 1", "description": "The subjects will receive SPARC1316.", "armGroupLabels": ["SPARC1316 Dose 1"]}, {"type": "DRUG", "name": "Placebo", "armGroupLabels": ["Placebo"], "otherNames": ["The subjects will receive a matching placebo by oral inhalation."]}, {"type": "DRUG", "name": "SPARC1316 Dose 2", "armGroupLabels": ["SPARC1316 Dose 2"]}, {"type": "DRUG", "name": "SPARC1316 Dose 3", "armGroupLabels": ["SPARC1316 Dose 3"]}, {"type": "DRUG", "name": "SPARC1316 Dose 4", "armGroupLabels": ["SPARC1316 Dose 4"]}, {"type": "DRUG", "name": "SPARC1316 Dose 5", "armGroupLabels": ["SPARC1316 Dose 5"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Subjects With Adverse Events", "description": "The no of adverse events will be assessed to evaluate the safety and tolerability of compound SO597 in healthy male subjects and asthma patients", "timeFrame": "Two (2) Weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects willing to provide informed consent\n* Male or female subjects aged 18 to 65 years inclusive\n* Body mass index (BMI) between 18.0 and 30.0 kg/m2 inclusive\n* Non-smokers or ex-smokers\n\nExclusion Criteria:\n\n* Subjects with a supine systolic blood pressure \u2265160 mmHg and/or a supine diastolic blood pressure \u2265100 mmHg\n* Subjects who have a significant infection or known inflammatory process on screening or admission.\n* Subjects who are unlikely to co-operate with the requirements of the study.\n* Positive serology for infectious disease (hepatitisB or C , HIV) at screening", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "SPARC study site", "city": "London", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "S0597 Dose 1", "description": "Subjects will be administered with SPARC1316 dose 1"}, {"id": "FG001", "title": "S0597 Dose 2", "description": "Subjects will receive SPARC1316 dose 2"}, {"id": "FG002", "title": "S0597 Dose 3", "description": "Subjects will receive SPARC1316 dose 3"}, {"id": "FG003", "title": "S0597 Dose 4", "description": "Subjects will receive SPARC1316 dose 4"}, {"id": "FG004", "title": "S0597 Dose 5", "description": "Subjects will receive SPARC1316 dose 5"}, {"id": "FG005", "title": "Placebo", "description": "Subjects will receive placebo"}], "periods": [{"title": "Part 1", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "6"}, {"groupId": "FG005", "numSubjects": "10"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "6"}, {"groupId": "FG005", "numSubjects": "10"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}, {"title": "Part 2", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "comment": "Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.", "numSubjects": "0"}, {"groupId": "FG004", "comment": "Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "6"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "comment": "Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually", "numSubjects": "0"}, {"groupId": "FG004", "comment": "Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "S0597 Dose 1", "description": "Subjects will be administered with S0597\n\nS0597: The subjects will receive S0597.\n\nPlacebo"}, {"id": "BG001", "title": "S0597 Dose 2", "description": "The subjects will receive placebo.\n\nS0597: The subjects will receive S0597.\n\nPlacebo"}, {"id": "BG002", "title": "S0597 Dose 3"}, {"id": "BG003", "title": "S0597 Dose 4"}, {"id": "BG004", "title": "S0597 Dose 5"}, {"id": "BG005", "title": "Placebo"}, {"id": "BG006", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "6"}, {"groupId": "BG005", "value": "10"}, {"groupId": "BG006", "value": "40"}]}], "measures": [{"title": "Age, Customized", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "33", "spread": "3.9"}, {"groupId": "BG001", "value": "28", "spread": "8.2"}, {"groupId": "BG002", "value": "28", "spread": "4.9"}, {"groupId": "BG003", "value": "27", "spread": "8.8"}, {"groupId": "BG004", "value": "31", "spread": "5.8"}, {"groupId": "BG005", "value": "27", "spread": "5.3"}, {"groupId": "BG006", "value": "29", "spread": "6.3"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "6"}, {"groupId": "BG005", "value": "10"}, {"groupId": "BG006", "value": "40"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Subjects With Adverse Events", "description": "The no of adverse events will be assessed to evaluate the safety and tolerability of compound SO597 in healthy male subjects and asthma patients", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Two (2) Weeks", "groups": [{"id": "OG000", "title": "S0597 Dose 1", "description": "The subjects will receive placebo.\n\nS0597: The subjects will receive S0597.\n\nPlacebo"}, {"id": "OG001", "title": "S0597 Dose 2"}, {"id": "OG002", "title": "S0597 Dose 3"}, {"id": "OG003", "title": "S0597 Dose 4"}, {"id": "OG004", "title": "S0597 Dose 5"}, {"id": "OG005", "title": "Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "6"}, {"groupId": "OG005", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "S0597 Dose 1", "description": "Subjects will be administered with S0597\n\nS0597: The subjects will receive S0597.\n\nPlacebo", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 0, "otherNumAtRisk": 6}, {"id": "EG001", "title": "S0597 Dose 2", "description": "The subjects will receive placebo.\n\nS0597: The subjects will receive S0597.\n\nPlacebo", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 0, "otherNumAtRisk": 6}, {"id": "EG002", "title": "S0597 Dose 3", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 0, "otherNumAtRisk": 6}, {"id": "EG003", "title": "S0597 Dose 4", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 0, "otherNumAtRisk": 6}, {"id": "EG004", "title": "S0597 Dose 5", "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 1, "otherNumAtRisk": 6}, {"id": "EG005", "title": "Placebo", "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 2, "otherNumAtRisk": 10}], "otherEvents": [{"term": "URTI", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Upper respiratory tract infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "headache", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true}, "pointOfContact": {"title": "Dr Shravanti Bhowmik", "organization": "SPARC", "phone": "+91 22 66455645"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}